Table 1 Integrated catalog of candidate genes combined from targeted bisulfite sequencing, RNA-seq, and ATAC-seq analysis

From: Epigenomic profiling of papillary thyroid carcinoma reveals distinct subtypes with clinical implications

Genomic location

Gene

Targeted bisulfite sequencing

RNA-seq (TCGA)

RNA-seq (GSE162515)

ATAC-seq (GSE162515)

Met diff (T1 - T2)

LFC

Padj

LFC

Padj

LFC

chr11:65352231-65353134

EHBP1L1

34.28

0.70

4.4E-20

1.28

5.5E-03

0.44

chr11:65359292-65360328

EHBP1L1

29.75

0.70

4.4E-20

1.28

5.5E-03

0.27

chr12:58132478-58132734

AGAP2

29.19

1.43

1.4E-36

2.74

1.6E-06

1.60

chr4:81109887-81110460

PRDM8

28.44

1.81

1.8E-47

2.29

2.1E-04

0.48

chr5:10649367-10650352

ANKRD33B

27.73

0.91

3.1E-12

2.20

1.2E-04

0.39

chr14:93153278-93154759

RIN3

26.37

0.82

2.6E-28

1.89

3.4E-05

0.39

chr12:58130870-58132047

AGAP2

24.94

1.43

1.4E-36

2.74

1.6E-06

0.58

chr12:58119909-58121551

AGAP2

24.36

1.43

1.4E-36

2.74

1.6E-06

0.36

chr16:67686860-67687674

CARMIL2

24.28

2.92

1.7E-77

4.30

3.4E-06

0.25

chr15:40583093-40583526

PLCB2

23.26

1.61

2.1E-47

2.62

3.4E-05

0.28

chr19:49841187-49841628

CD37

22.72

2.19

5.2E-57

3.85

4.0E-06

0.98

chr19:17877468-17877777

FCHO1

22.70

0.77

2.0E-06

2.47

3.1E-03

0.28

chr5:43037259-43037520

ANXA2R

22.32

1.24

1.1E-27

2.06

7.4E-05

1.99

chr2:11774310-11774521

GREB1

22.24

-0.87

4.7E-05

−2.15

2.0E-02

0.72

chr19:15563869-15564223

RASAL3

21.03

1.76

5.7E-57

3.01

3.2E-06

0.32

chr19:15568027-15569227

RASAL3

20.10

1.76

5.7E-57

3.01

3.2E-06

0.87

chr21:45789090-45789373

TRPM2

20.00

1.38

2.0E-36

1.95

3.1E-04

0.63

chr4:81128229-81128691

PRDM8

19.74

1.81

1.8E-47

2.29

2.1E-04

0.29

chr16:67681975-67683924

CARMIL2

18.68

2.92

1.7E-77

4.30

3.4E-06

0.76

chr2:198029068-198029438

ANKRD44

17.22

1.08

8.1E-35

2.75

5.1E-07

0.34

chr12:54764065-54764510

GPR84

16.72

1.48

8.2E-33

1.90

1.4E-02

0.30

chr17:3847999-3848570

ATP2A3

16.40

1.27

6.8E-32

2.84

3.4E-06

1.47

chr17:14201726-14202052

HS3ST3B1

15.68

1.29

8.7E-28

3.00

3.0E-07

1.88

chr19:49842654-49843628

CD37

15.67

2.19

5.2E-57

3.85

4.0E-06

0.64

chr19:1070985-1071812

ARHGAP45

15.06

1.09

5.4E-33

2.61

3.4E-05

0.52

chr7:5336513-5336894

SLC29A4

-16.26

-0.90

5.2E-06

−2.22

9.6E-03

2.48

chr22:50483350-50483579

IL17REL

-16.26

2.55

1.1E-29

5.48

1.9E-03

0.32

chr16:29675845-29676120

SPN

-17.67

1.77

2.5E-44

2.64

6.5E-04

2.61

chr11:65408344-65408631

SIPA1

-18.32

0.62

3.8E-14

1.72

5.4E-05

2.42

chr19:13207375-13207621

LYL1

-19.67

0.94

1.0E-16

2.40

1.1E-05

1.84

chr11:67176945-67177169

TBC1D10C

-21.63

0.79

9.2E-15

1.91

1.5E-04

2.71

chr17:72347924-72348322

BTBD17

-21.72

−1.76

1.1E-05

-3.49

3.5E-02

0.70

chr19:3178741-3179986

S1PR4

-24.25

1.71

2.0E-45

3.32

4.7E-07

2.61

chr12:6664425-6665336

IFFO1

-27.25

1.07

3.0E-37

1.46

4.1E-04

2.66

chr11:63974829-63975048

FERMT3

-37.59

1.83

2.4E-54

2.68

1.0E-05

2.47

  1. Met diff difference in average DNA methylation, LFC Log2(Fold Change); Padj Adjusted p value.